| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.83e-13 | 46 | 27 | 7 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.44e-09 | 188 | 27 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.59e-05 | 891 | 27 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 9.61e-05 | 11 | 27 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 2.36e-04 | 17 | 27 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.93e-04 | 303 | 27 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.74e-03 | 1356 | 27 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | heparin binding | 2.16e-03 | 192 | 27 | 3 | GO:0008201 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.91e-03 | 1160 | 27 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.51e-03 | 268 | 27 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 5.60e-03 | 83 | 27 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | chloride channel activity | 6.00e-03 | 86 | 27 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.51e-03 | 562 | 27 | 4 | GO:0003712 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 2.92e-05 | 46 | 27 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 7.38e-05 | 10 | 27 | 2 | GO:0030321 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 7.38e-05 | 10 | 27 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.08e-04 | 12 | 27 | 2 | GO:0038063 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.15e-04 | 377 | 27 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.17e-04 | 378 | 27 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.18e-04 | 379 | 27 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 1.96e-04 | 16 | 27 | 2 | GO:0006369 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 2.49e-04 | 18 | 27 | 2 | GO:0038065 | |
| GeneOntologyBiologicalProcess | RNA 3'-end processing | 2.80e-04 | 98 | 27 | 3 | GO:0031123 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 WDR33 COL28A1 | 1.27e-17 | 88 | 28 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.93e-11 | 21 | 28 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 COL28A1 | 1.82e-08 | 530 | 28 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | collagen type IV trimer | 4.29e-08 | 6 | 28 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 COL28A1 | 1.13e-07 | 656 | 28 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 COL28A1 | 1.16e-07 | 658 | 28 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.20e-07 | 8 | 28 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.20e-07 | 8 | 28 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.20e-07 | 8 | 28 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.13e-07 | 332 | 28 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 9.43e-06 | 31 | 28 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | basement membrane | 2.03e-05 | 122 | 28 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.13e-04 | 12 | 28 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.13e-04 | 12 | 28 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 5.51e-04 | 26 | 28 | 2 | GO:0005847 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.64e-03 | 57 | 28 | 2 | GO:0034707 | |
| HumanPheno | Glomerular basement membrane lamellation | 2.77e-05 | 3 | 16 | 2 | HP:0030034 | |
| HumanPheno | Thin glomerular basement membrane | 2.77e-05 | 3 | 16 | 2 | HP:0012577 | |
| HumanPheno | Hypokalemic hypochloremic metabolic alkalosis | 2.77e-05 | 3 | 16 | 2 | HP:0004909 | |
| HumanPheno | Hypochloremic metabolic alkalosis | 5.53e-05 | 4 | 16 | 2 | HP:0005977 | |
| HumanPheno | Abnormal urine chloride concentration | 9.20e-05 | 5 | 16 | 2 | HP:0012600 | |
| HumanPheno | Hyperchloriduria | 9.20e-05 | 5 | 16 | 2 | HP:0002914 | |
| HumanPheno | Abnormal circulating renin concentration | 1.31e-04 | 33 | 16 | 3 | HP:0040084 | |
| HumanPheno | Abnormal circulating prostaglandin circulation | 1.38e-04 | 6 | 16 | 2 | HP:0011023 | |
| HumanPheno | Hyperprostaglandinuria | 1.38e-04 | 6 | 16 | 2 | HP:0003527 | |
| HumanPheno | Impaired renal concentrating ability | 1.92e-04 | 7 | 16 | 2 | HP:0004727 | |
| HumanPheno | Hypochloremia | 1.92e-04 | 7 | 16 | 2 | HP:0003113 | |
| HumanPheno | Abnormal blood chloride concentration | 2.17e-04 | 39 | 16 | 3 | HP:0011422 | |
| HumanPheno | Mixed hearing impairment | 2.34e-04 | 40 | 16 | 3 | HP:0000410 | |
| HumanPheno | Polyhydramnios | 2.39e-04 | 312 | 16 | 6 | HP:0001561 | |
| HumanPheno | Abnormal circulating unsaturated fatty acid concentration | 2.56e-04 | 8 | 16 | 2 | HP:0011022 | |
| HumanPheno | Hyperactive renin-angiotensin system | 2.56e-04 | 8 | 16 | 2 | HP:0000841 | |
| HumanPheno | Abnormal circulating eicosanoid concentration | 2.56e-04 | 8 | 16 | 2 | HP:0030361 | |
| HumanPheno | Hypokalemic metabolic alkalosis | 3.29e-04 | 9 | 16 | 2 | HP:0001960 | |
| HumanPheno | Increased urinary potassium | 3.29e-04 | 9 | 16 | 2 | HP:0003081 | |
| HumanPheno | Impaired renal function | 3.29e-04 | 9 | 16 | 2 | HP:0000087 | |
| HumanPheno | Pilomatrixoma | 3.29e-04 | 9 | 16 | 2 | HP:0030434 | |
| HumanPheno | Lenticonus | 4.10e-04 | 10 | 16 | 2 | HP:0001142 | |
| HumanPheno | Hypernatriuria | 4.10e-04 | 10 | 16 | 2 | HP:0012605 | |
| HumanPheno | Abnormality of the amniotic fluid | 4.60e-04 | 504 | 16 | 7 | HP:0001560 | |
| HumanPheno | Abnormality of renal physiology | 5.18e-04 | 691 | 16 | 8 | HP:0000082 | |
| HumanPheno | Hypokalemic alkalosis | 5.99e-04 | 12 | 16 | 2 | HP:0001949 | |
| HumanPheno | Fetal polyuria | 5.99e-04 | 12 | 16 | 2 | HP:0001563 | |
| HumanPheno | Thickened glomerular basement membrane | 5.99e-04 | 12 | 16 | 2 | HP:0004722 | |
| HumanPheno | Abnormality of renin-angiotensin system | 6.04e-04 | 55 | 16 | 3 | HP:0000847 | |
| HumanPheno | Stage 5 chronic kidney disease | 6.70e-04 | 135 | 16 | 4 | HP:0003774 | |
| HumanPheno | Marcus Gunn jaw winking synkinesis | 7.07e-04 | 13 | 16 | 2 | HP:0025186 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 7.07e-04 | 13 | 16 | 2 | HP:0033282 | |
| MousePheno | abnormal urination | 1.91e-07 | 148 | 25 | 6 | MP:0001756 | |
| MousePheno | polyuria | 4.49e-07 | 89 | 25 | 5 | MP:0001762 | |
| MousePheno | sensorineural hearing impairment | 5.64e-07 | 38 | 25 | 4 | MP:0006329 | |
| MousePheno | hematuria | 4.80e-06 | 19 | 25 | 3 | MP:0005161 | |
| MousePheno | renal cast | 2.91e-05 | 34 | 25 | 3 | MP:0011402 | |
| MousePheno | sensorineural hearing loss | 3.77e-05 | 37 | 25 | 3 | MP:0004740 | |
| MousePheno | podocyte foot process effacement | 4.09e-05 | 38 | 25 | 3 | MP:0008140 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 6.38e-05 | 44 | 25 | 3 | MP:0011348 | |
| MousePheno | abnormal blood circulation | 7.41e-05 | 845 | 25 | 8 | MP:0002128 | |
| MousePheno | abnormal urine sodium level | 9.94e-05 | 51 | 25 | 3 | MP:0006274 | |
| MousePheno | decreased urine osmolality | 1.18e-04 | 54 | 25 | 3 | MP:0002988 | |
| MousePheno | abnormal renal filtration | 1.18e-04 | 54 | 25 | 3 | MP:0013285 | |
| MousePheno | abnormal podocyte foot process morphology | 1.25e-04 | 55 | 25 | 3 | MP:0008059 | |
| MousePheno | abnormal urine homeostasis | 1.37e-04 | 466 | 25 | 6 | MP:0009643 | |
| MousePheno | increased blood urea nitrogen level | 1.38e-04 | 289 | 25 | 5 | MP:0005565 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 1.67e-04 | 700 | 25 | 7 | MP:0011098 | |
| MousePheno | albuminuria | 1.87e-04 | 63 | 25 | 3 | MP:0002871 | |
| MousePheno | abnormal urine osmolality | 2.05e-04 | 65 | 25 | 3 | MP:0002987 | |
| MousePheno | abnormal podocyte morphology | 2.56e-04 | 70 | 25 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 2.56e-04 | 70 | 25 | 3 | MP:0011497 | |
| MousePheno | abnormal kidney vasculature morphology | 2.89e-04 | 73 | 25 | 3 | MP:0000530 | |
| MousePheno | decreased renal glomerular filtration rate | 3.18e-04 | 15 | 25 | 2 | MP:0005528 | |
| MousePheno | abnormal collagen level | 3.63e-04 | 16 | 25 | 2 | MP:0020252 | |
| MousePheno | abnormal glomerular mesangium morphology | 4.22e-04 | 83 | 25 | 3 | MP:0011339 | |
| MousePheno | abnormal pupil morphology | 4.53e-04 | 85 | 25 | 3 | MP:0001317 | |
| MousePheno | thin myocardium | 4.53e-04 | 85 | 25 | 3 | MP:0002652 | |
| MousePheno | glomerular crescent | 5.15e-04 | 19 | 25 | 2 | MP:0011506 | |
| MousePheno | internal hemorrhage | 5.33e-04 | 387 | 25 | 5 | MP:0001634 | |
| MousePheno | abnormal blood urea nitrogen level | 5.46e-04 | 389 | 25 | 5 | MP:0005265 | |
| MousePheno | impaired hearing | 6.13e-04 | 223 | 25 | 4 | MP:0006325 | |
| MousePheno | abnormal face shape | 6.32e-04 | 21 | 25 | 2 | MP:0030071 | |
| MousePheno | abnormal renal tubule morphology | 6.55e-04 | 227 | 25 | 4 | MP:0002703 | |
| MousePheno | embryonic lethality during organogenesis | 6.57e-04 | 876 | 25 | 7 | MP:0006207 | |
| MousePheno | dilated renal tubule | 7.50e-04 | 101 | 25 | 3 | MP:0002705 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 7.58e-04 | 236 | 25 | 4 | MP:0011967 | |
| MousePheno | intracranial hemorrhage | 8.17e-04 | 104 | 25 | 3 | MP:0001915 | |
| MousePheno | abnormal renal glomerular capsule morphology | 8.87e-04 | 107 | 25 | 3 | MP:0002828 | |
| MousePheno | abnormal renal glomerular filtration rate | 8.98e-04 | 25 | 25 | 2 | MP:0002847 | |
| MousePheno | hemorrhage | 9.16e-04 | 664 | 25 | 6 | MP:0001914 | |
| MousePheno | uremia | 9.24e-04 | 437 | 25 | 5 | MP:0009644 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 1.05e-03 | 27 | 25 | 2 | MP:0011409 | |
| MousePheno | abnormal renal/urinary system physiology | 1.16e-03 | 695 | 25 | 6 | MP:0005502 | |
| MousePheno | abnormal renal glomerular filtration | 1.21e-03 | 29 | 25 | 2 | MP:0013284 | |
| MousePheno | decreased urine sodium level | 1.21e-03 | 29 | 25 | 2 | MP:0006317 | |
| MousePheno | renal tubule atrophy | 1.30e-03 | 30 | 25 | 2 | MP:0011346 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 1.38e-03 | 31 | 25 | 2 | MP:0011349 | |
| MousePheno | pale kidney | 1.57e-03 | 33 | 25 | 2 | MP:0004969 | |
| MousePheno | abnormal renal corpuscle morphology | 1.69e-03 | 293 | 25 | 4 | MP:0002827 | |
| MousePheno | abnormal urine potassium level | 1.86e-03 | 36 | 25 | 2 | MP:0004820 | |
| MousePheno | abnormal inner ear morphology | 1.91e-03 | 303 | 25 | 4 | MP:0000026 | |
| MousePheno | premature death | 1.92e-03 | 1051 | 25 | 7 | MP:0002083 | |
| MousePheno | irregularly shaped pupil | 2.18e-03 | 39 | 25 | 2 | MP:0001319 | |
| MousePheno | abnormal basement membrane morphology | 2.30e-03 | 40 | 25 | 2 | MP:0004272 | |
| MousePheno | increased urine protein level | 2.30e-03 | 149 | 25 | 3 | MP:0002962 | |
| MousePheno | abnormal red blood cell distribution width | 2.30e-03 | 319 | 25 | 4 | MP:0010066 | |
| MousePheno | abnormal kidney cortex morphology | 2.44e-03 | 324 | 25 | 4 | MP:0000521 | |
| Domain | Collagen | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 WDR33 COL28A1 | 2.71e-17 | 85 | 28 | 10 | PF01391 |
| Domain | Collagen | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 WDR33 COL28A1 | 2.71e-17 | 85 | 28 | 10 | IPR008160 |
| Domain | C4 | 6.02e-08 | 6 | 28 | 3 | SM00111 | |
| Domain | - | 6.02e-08 | 6 | 28 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 6.02e-08 | 6 | 28 | 3 | IPR001442 | |
| Domain | NC1_IV | 6.02e-08 | 6 | 28 | 3 | PS51403 | |
| Domain | C4 | 6.02e-08 | 6 | 28 | 3 | PF01413 | |
| Domain | Cl_channel-K | 2.17e-06 | 2 | 28 | 2 | IPR002250 | |
| Domain | - | 4.33e-06 | 74 | 28 | 4 | 3.40.50.410 | |
| Domain | VWF_A | 1.38e-05 | 99 | 28 | 4 | IPR002035 | |
| Domain | CTDL_fold | 1.88e-05 | 107 | 28 | 4 | IPR016187 | |
| Domain | Cl-channel_core | 7.75e-05 | 9 | 28 | 2 | IPR014743 | |
| Domain | - | 7.75e-05 | 9 | 28 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 7.75e-05 | 9 | 28 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 7.75e-05 | 9 | 28 | 2 | IPR001807 | |
| Domain | VWA | 7.93e-05 | 56 | 28 | 3 | PF00092 | |
| Domain | VWFA | 2.47e-04 | 82 | 28 | 3 | PS50234 | |
| Domain | CBS | 2.57e-04 | 16 | 28 | 2 | SM00116 | |
| Domain | VWA | 2.65e-04 | 84 | 28 | 3 | SM00327 | |
| Domain | CBS_dom | 4.05e-04 | 20 | 28 | 2 | IPR000644 | |
| Domain | CBS | 4.05e-04 | 20 | 28 | 2 | PF00571 | |
| Domain | CBS | 4.05e-04 | 20 | 28 | 2 | PS51371 | |
| Domain | TSPN | 5.38e-04 | 23 | 28 | 2 | SM00210 | |
| Domain | Znf_FYVE_PHD | 1.35e-03 | 147 | 28 | 3 | IPR011011 | |
| Domain | Laminin_G | 3.40e-03 | 58 | 28 | 2 | IPR001791 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.72e-15 | 41 | 26 | 8 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.88e-15 | 44 | 26 | 8 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.12e-13 | 61 | 26 | 8 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.47e-13 | 67 | 26 | 8 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.06e-13 | 76 | 26 | 8 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.86e-12 | 90 | 26 | 8 | M631 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.58e-10 | 53 | 26 | 6 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.48e-09 | 64 | 26 | 6 | M26953 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.33e-08 | 258 | 26 | 8 | MM14572 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.84e-08 | 50 | 26 | 5 | MM14796 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.29e-08 | 300 | 26 | 8 | M610 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.32e-08 | 20 | 26 | 4 | MM15061 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.94e-08 | 114 | 26 | 6 | MM14571 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.87e-08 | 61 | 26 | 5 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.68e-07 | 140 | 26 | 6 | M587 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.16e-07 | 32 | 26 | 4 | MM14924 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.43e-07 | 38 | 26 | 4 | MM14969 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.63e-07 | 10 | 26 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.63e-07 | 10 | 26 | 3 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.10e-07 | 11 | 26 | 3 | M15422 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.70e-07 | 42 | 26 | 4 | M7169 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.21e-06 | 12 | 26 | 3 | MM1526 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.41e-06 | 46 | 26 | 4 | M198 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.57e-06 | 13 | 26 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.57e-06 | 13 | 26 | 3 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.00e-06 | 14 | 26 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.00e-06 | 14 | 26 | 3 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.50e-06 | 15 | 26 | 3 | MM14922 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.50e-06 | 15 | 26 | 3 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.36e-06 | 57 | 26 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.60e-06 | 58 | 26 | 4 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.86e-06 | 59 | 26 | 4 | M27218 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.46e-06 | 18 | 26 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.46e-06 | 18 | 26 | 3 | MM14882 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.03e-06 | 63 | 26 | 4 | M11187 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.06e-06 | 66 | 26 | 4 | M18 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 6.22e-06 | 20 | 26 | 3 | M497 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 6.22e-06 | 20 | 26 | 3 | M15394 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 6.22e-06 | 20 | 26 | 3 | MM15469 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 9.58e-06 | 74 | 26 | 4 | M160 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 9.63e-06 | 23 | 26 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 9.63e-06 | 23 | 26 | 3 | MM1427 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.07e-05 | 76 | 26 | 4 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.07e-05 | 76 | 26 | 4 | MM14867 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.41e-05 | 26 | 26 | 3 | MM14793 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.66e-05 | 85 | 26 | 4 | M16441 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.97e-05 | 29 | 26 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.97e-05 | 29 | 26 | 3 | MM15444 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.19e-05 | 30 | 26 | 3 | M27216 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 6.55e-05 | 43 | 26 | 3 | M53 | |
| Pathway | WP_DISTAL_CONVOLUTED_TUBULE_1_DCT1_CELL | 6.83e-05 | 7 | 26 | 2 | MM15929 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 9.12e-05 | 418 | 26 | 6 | MM15587 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.96e-04 | 62 | 26 | 3 | MM15426 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.47e-04 | 67 | 26 | 3 | M27694 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.39e-04 | 532 | 26 | 6 | M27870 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.81e-04 | 84 | 26 | 3 | M7098 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 6.08e-04 | 91 | 26 | 3 | M27101 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 7.10e-04 | 96 | 26 | 3 | M39834 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 9.47e-04 | 106 | 26 | 3 | M27200 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.25e-03 | 261 | 26 | 4 | MM15676 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.69e-03 | 42 | 26 | 2 | M27272 | |
| Pathway | PID_HNF3A_PATHWAY | 2.95e-03 | 44 | 26 | 2 | M285 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.95e-03 | 44 | 26 | 2 | MM15527 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.97e-03 | 158 | 26 | 3 | MM14791 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 3.08e-03 | 45 | 26 | 2 | M39864 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 3.13e-03 | 161 | 26 | 3 | M39770 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.23e-03 | 339 | 26 | 4 | M39736 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.49e-03 | 183 | 26 | 3 | M997 | |
| Pathway | WP_FOCAL_ADHESION | 4.77e-03 | 187 | 26 | 3 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.67e-03 | 199 | 26 | 3 | M7253 | |
| Pathway | PID_RB_1PATHWAY | 6.34e-03 | 65 | 26 | 2 | M279 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.08e-09 | 4 | 29 | 3 | 7827955 | |
| Pubmed | 4.85e-09 | 167 | 29 | 6 | 22159717 | ||
| Pubmed | 5.21e-09 | 5 | 29 | 3 | 9409248 | ||
| Pubmed | 6.43e-09 | 175 | 29 | 6 | 28071719 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 1.04e-08 | 6 | 29 | 3 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 1.04e-08 | 6 | 29 | 3 | 9506531 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 7495302 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 1.04e-08 | 6 | 29 | 3 | 9673377 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 1.04e-08 | 6 | 29 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 1.04e-08 | 6 | 29 | 3 | 6811420 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 1.04e-08 | 6 | 29 | 3 | 19275937 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 1.04e-08 | 6 | 29 | 3 | 6389236 | |
| Pubmed | 1.04e-08 | 6 | 29 | 3 | 12225806 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 10639489 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 7521231 | ||
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 1.82e-08 | 7 | 29 | 3 | 8006028 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.82e-08 | 7 | 29 | 3 | 10716744 | |
| Pubmed | 1.82e-08 | 7 | 29 | 3 | 1724753 | ||
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 10382266 | ||
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 3997552 | ||
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 29422532 | ||
| Pubmed | 2.91e-08 | 8 | 29 | 3 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 2.91e-08 | 8 | 29 | 3 | 11867580 | |
| Pubmed | 4.36e-08 | 9 | 29 | 3 | 9878537 | ||
| Pubmed | 4.36e-08 | 9 | 29 | 3 | 8562707 | ||
| Pubmed | 4.36e-08 | 9 | 29 | 3 | 12101409 | ||
| Pubmed | 4.36e-08 | 9 | 29 | 3 | 10880400 | ||
| Pubmed | 4.36e-08 | 9 | 29 | 3 | 8995276 | ||
| Pubmed | 6.23e-08 | 10 | 29 | 3 | 9136074 | ||
| Pubmed | 6.23e-08 | 10 | 29 | 3 | 9415455 | ||
| Pubmed | 8.10e-08 | 268 | 29 | 6 | 33640491 | ||
| Pubmed | 8.56e-08 | 11 | 29 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 8.56e-08 | 11 | 29 | 3 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 8.56e-08 | 11 | 29 | 3 | 9731539 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.01e-08 | 135 | 29 | 5 | 28675934 | |
| Pubmed | 1.14e-07 | 12 | 29 | 3 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.14e-07 | 12 | 29 | 3 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.14e-07 | 12 | 29 | 3 | 12180907 | |
| Pubmed | 1.14e-07 | 12 | 29 | 3 | 16024816 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.48e-07 | 13 | 29 | 3 | 9833687 | |
| Pubmed | 1.68e-07 | 153 | 29 | 5 | 25037231 | ||
| Pubmed | 1.89e-07 | 14 | 29 | 3 | 12878203 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 2.10e-07 | 62 | 29 | 4 | 28344315 | |
| Pubmed | 2.36e-07 | 15 | 29 | 3 | 10625553 | ||
| Pubmed | 2.36e-07 | 15 | 29 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 2.36e-07 | 15 | 29 | 3 | 10706142 | |
| Pubmed | 2.90e-07 | 16 | 29 | 3 | 15878328 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.95e-07 | 351 | 29 | 6 | 38297188 | |
| Pubmed | 4.22e-07 | 18 | 29 | 3 | 9160753 | ||
| Pubmed | 5.01e-07 | 19 | 29 | 3 | 15689378 | ||
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 6.71e-07 | 2 | 29 | 2 | 24052634 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 6.71e-07 | 2 | 29 | 2 | 8544406 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 19357112 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12768082 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 28475860 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 6.71e-07 | 2 | 29 | 2 | 27335120 | |
| Pubmed | WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription. | 6.71e-07 | 2 | 29 | 2 | 29196535 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25229338 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 8812470 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 6.71e-07 | 2 | 29 | 2 | 20029656 | |
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 6.71e-07 | 2 | 29 | 2 | 28674241 | |
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 6.71e-07 | 2 | 29 | 2 | 20805576 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25919862 | ||
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 6.71e-07 | 2 | 29 | 2 | 16235097 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 6.71e-07 | 2 | 29 | 2 | 9916798 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 9916791 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 9537506 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 6.71e-07 | 2 | 29 | 2 | 15280517 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 6.71e-07 | 2 | 29 | 2 | 35090027 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15880327 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 29742505 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 38214412 | ||
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 6.71e-07 | 2 | 29 | 2 | 15044642 | |
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 6.71e-07 | 2 | 29 | 2 | 17216251 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 35369551 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 6.71e-07 | 2 | 29 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 6.71e-07 | 2 | 29 | 2 | 12028435 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 6.71e-07 | 2 | 29 | 2 | 25083577 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 20847057 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 6.71e-07 | 2 | 29 | 2 | 38069401 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 25307543 | ||
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 6.71e-07 | 2 | 29 | 2 | 8041726 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 18661361 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 6.71e-07 | 2 | 29 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 6.71e-07 | 2 | 29 | 2 | 16895672 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 32232700 | ||
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 6.71e-07 | 2 | 29 | 2 | 18648499 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 11014860 | ||
| Pubmed | 6.86e-07 | 21 | 29 | 3 | 27856617 | ||
| Pubmed | 1.20e-06 | 425 | 29 | 6 | 24999758 | ||
| Pubmed | 1.34e-06 | 26 | 29 | 3 | 24742657 | ||
| Interaction | SP7 interactions | 1.50e-07 | 304 | 28 | 7 | int:SP7 | |
| Interaction | DCN interactions | 3.54e-07 | 43 | 28 | 4 | int:DCN | |
| Interaction | SAA1 interactions | 8.99e-07 | 54 | 28 | 4 | int:SAA1 | |
| Interaction | CRX interactions | 1.13e-06 | 254 | 28 | 6 | int:CRX | |
| Interaction | ELF5 interactions | 1.66e-06 | 147 | 28 | 5 | int:ELF5 | |
| Interaction | HABP2 interactions | 1.93e-06 | 18 | 28 | 3 | int:HABP2 | |
| Interaction | OSM interactions | 2.70e-06 | 20 | 28 | 3 | int:OSM | |
| Interaction | EGR2 interactions | 3.48e-06 | 171 | 28 | 5 | int:EGR2 | |
| Interaction | LHX3 interactions | 5.11e-06 | 185 | 28 | 5 | int:LHX3 | |
| Interaction | TGFBI interactions | 5.41e-06 | 25 | 28 | 3 | int:TGFBI | |
| Interaction | FEV interactions | 8.03e-06 | 203 | 28 | 5 | int:FEV | |
| Interaction | PAX8 interactions | 1.61e-05 | 111 | 28 | 4 | int:PAX8 | |
| Interaction | SUPT5H interactions | 1.71e-05 | 408 | 28 | 6 | int:SUPT5H | |
| Interaction | TBR1 interactions | 1.73e-05 | 113 | 28 | 4 | int:TBR1 | |
| Interaction | SMAD1 interactions | 1.92e-05 | 243 | 28 | 5 | int:SMAD1 | |
| Interaction | TBXT interactions | 1.92e-05 | 116 | 28 | 4 | int:TBXT | |
| Interaction | PAX7 interactions | 2.49e-05 | 124 | 28 | 4 | int:PAX7 | |
| Interaction | PAX9 interactions | 3.00e-05 | 130 | 28 | 4 | int:PAX9 | |
| Interaction | CD93 interactions | 3.28e-05 | 45 | 28 | 3 | int:CD93 | |
| Interaction | CPSF3 interactions | 4.73e-05 | 146 | 28 | 4 | int:CPSF3 | |
| Interaction | SERPINE2 interactions | 6.34e-05 | 56 | 28 | 3 | int:SERPINE2 | |
| Interaction | CSTF2 interactions | 7.61e-05 | 165 | 28 | 4 | int:CSTF2 | |
| Interaction | FBLN2 interactions | 1.04e-04 | 66 | 28 | 3 | int:FBLN2 | |
| Interaction | MMP9 interactions | 1.08e-04 | 67 | 28 | 3 | int:MMP9 | |
| Interaction | ALG13 interactions | 1.14e-04 | 183 | 28 | 4 | int:ALG13 | |
| Interaction | LHX2 interactions | 1.14e-04 | 183 | 28 | 4 | int:LHX2 | |
| Interaction | DUXA interactions | 1.22e-04 | 12 | 28 | 2 | int:DUXA | |
| Interaction | GATA3 interactions | 1.23e-04 | 187 | 28 | 4 | int:GATA3 | |
| Interaction | PAX6 interactions | 1.34e-04 | 366 | 28 | 5 | int:PAX6 | |
| Interaction | PCAT1 interactions | 1.93e-04 | 15 | 28 | 2 | int:PCAT1 | |
| Interaction | SOX7 interactions | 1.98e-04 | 82 | 28 | 3 | int:SOX7 | |
| Interaction | IRF4 interactions | 2.20e-04 | 85 | 28 | 3 | int:IRF4 | |
| Interaction | GSC interactions | 2.35e-04 | 87 | 28 | 3 | int:GSC | |
| Interaction | HMGN2 interactions | 2.38e-04 | 222 | 28 | 4 | int:HMGN2 | |
| Interaction | ERG interactions | 2.43e-04 | 223 | 28 | 4 | int:ERG | |
| Interaction | FIP1L1 interactions | 2.51e-04 | 225 | 28 | 4 | int:FIP1L1 | |
| Interaction | NUP35 interactions | 2.65e-04 | 424 | 28 | 5 | int:NUP35 | |
| Interaction | FOXI1 interactions | 2.78e-04 | 92 | 28 | 3 | int:FOXI1 | |
| Interaction | SOX10 interactions | 2.78e-04 | 92 | 28 | 3 | int:SOX10 | |
| Interaction | SOX9 interactions | 3.24e-04 | 97 | 28 | 3 | int:SOX9 | |
| Interaction | AR interactions | 3.27e-04 | 992 | 28 | 7 | int:AR | |
| Interaction | ASF1A interactions | 3.69e-04 | 249 | 28 | 4 | int:ASF1A | |
| Interaction | LHX1 interactions | 3.87e-04 | 103 | 28 | 3 | int:LHX1 | |
| Interaction | AJUBA interactions | 3.87e-04 | 103 | 28 | 3 | int:AJUBA | |
| Interaction | CPSF1 interactions | 4.04e-04 | 255 | 28 | 4 | int:CPSF1 | |
| Interaction | WDR59 interactions | 4.57e-04 | 109 | 28 | 3 | int:WDR59 | |
| Interaction | NUDT16 interactions | 4.63e-04 | 23 | 28 | 2 | int:NUDT16 | |
| Interaction | EN1 interactions | 4.69e-04 | 110 | 28 | 3 | int:EN1 | |
| Interaction | CEP170P1 interactions | 5.08e-04 | 113 | 28 | 3 | int:CEP170P1 | |
| Interaction | MIA2 interactions | 5.08e-04 | 113 | 28 | 3 | int:MIA2 | |
| Interaction | MATN2 interactions | 5.08e-04 | 113 | 28 | 3 | int:MATN2 | |
| Interaction | HNF4A interactions | 5.37e-04 | 275 | 28 | 4 | int:HNF4A | |
| Interaction | ETS1 interactions | 6.20e-04 | 121 | 28 | 3 | int:ETS1 | |
| Interaction | RBBP5 interactions | 6.30e-04 | 287 | 28 | 4 | int:RBBP5 | |
| Interaction | TLX3 interactions | 6.63e-04 | 291 | 28 | 4 | int:TLX3 | |
| Interaction | PLOD1 interactions | 6.72e-04 | 292 | 28 | 4 | int:PLOD1 | |
| Interaction | ANTXR2 interactions | 7.38e-04 | 29 | 28 | 2 | int:ANTXR2 | |
| Interaction | MYB interactions | 8.16e-04 | 133 | 28 | 3 | int:MYB | |
| Interaction | SPATA1 interactions | 8.44e-04 | 31 | 28 | 2 | int:SPATA1 | |
| Interaction | ETV5 interactions | 9.57e-04 | 33 | 28 | 2 | int:ETV5 | |
| Interaction | DTX2 interactions | 1.06e-03 | 330 | 28 | 4 | int:DTX2 | |
| Interaction | E2F5 interactions | 1.14e-03 | 36 | 28 | 2 | int:E2F5 | |
| Interaction | HOXB2 interactions | 1.14e-03 | 36 | 28 | 2 | int:HOXB2 | |
| Interaction | OXSR1 interactions | 1.27e-03 | 155 | 28 | 3 | int:OXSR1 | |
| Cytoband | 1p36 | 4.09e-04 | 47 | 29 | 2 | 1p36 | |
| Cytoband | 20q13.33 | 1.15e-03 | 79 | 29 | 2 | 20q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 1.33e-03 | 85 | 29 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 2.36e-03 | 422 | 29 | 3 | chr20q13 | |
| Cytoband | 6p21.3 | 1.09e-02 | 250 | 29 | 2 | 6p21.3 | |
| GeneFamily | Collagens | 1.14e-16 | 46 | 20 | 8 | 490 | |
| GeneFamily | Chloride voltage-gated channels | 5.20e-05 | 10 | 20 | 2 | 302 | |
| Coexpression | NABA_COLLAGENS | 1.10e-16 | 43 | 29 | 8 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.34e-16 | 44 | 29 | 8 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | 4.07e-10 | 270 | 29 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.70e-10 | 275 | 29 | 8 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.07e-07 | 40 | 29 | 4 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 COL28A1 | 8.88e-07 | 1008 | 29 | 9 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A3 COL4A4 COL6A5 COL11A2 COL25A1 SFTPD COL20A1 COL28A1 | 1.03e-06 | 1026 | 29 | 9 | M5889 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.12e-06 | 23 | 29 | 3 | M48001 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL | 1.36e-05 | 42 | 29 | 3 | M45688 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 6.73e-05 | 200 | 29 | 4 | M5063 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ENS_GLIA | 7.79e-05 | 75 | 29 | 3 | M40269 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 1.79e-04 | 18 | 29 | 2 | M47984 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-07 | 183 | 29 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-07 | 189 | 29 | 5 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-07 | 195 | 29 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-07 | 196 | 29 | 5 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-07 | 196 | 29 | 5 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 198 | 29 | 5 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 156 | 29 | 4 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.59e-06 | 162 | 29 | 4 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-06 | 168 | 29 | 4 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-06 | 173 | 29 | 4 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 175 | 29 | 4 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.98e-06 | 176 | 29 | 4 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.09e-06 | 177 | 29 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-06 | 177 | 29 | 4 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-06 | 179 | 29 | 4 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-06 | 179 | 29 | 4 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-06 | 184 | 29 | 4 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 186 | 29 | 4 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 186 | 29 | 4 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 6.20e-06 | 186 | 29 | 4 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 6.20e-06 | 186 | 29 | 4 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-06 | 188 | 29 | 4 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-06 | 188 | 29 | 4 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.46e-06 | 188 | 29 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-06 | 188 | 29 | 4 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-06 | 188 | 29 | 4 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-06 | 188 | 29 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-06 | 188 | 29 | 4 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.46e-06 | 188 | 29 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 189 | 29 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-06 | 190 | 29 | 4 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 190 | 29 | 4 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.88e-06 | 191 | 29 | 4 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.88e-06 | 191 | 29 | 4 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 29 | 4 | 32e4a180037e516c5cc798cd9dada9385e0f43ae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 29 | 4 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.17e-06 | 193 | 29 | 4 | 54506c0da2f219f472b95e8935a78b657a8dec41 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.17e-06 | 193 | 29 | 4 | 2d42721fac1bee294ede47d609bebb3e7d36bf0c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-06 | 193 | 29 | 4 | dd9874898587fe9fd9cf2aebc2e0579dcf06944e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-06 | 194 | 29 | 4 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | droplet-Kidney-KIDNEY-1m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-06 | 194 | 29 | 4 | 837cee7e6147d92a2f4b86f1ed761a9bfe65b61d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 195 | 29 | 4 | 60d08fb27469d1e247bc47b651d7023ba82cf92f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 195 | 29 | 4 | 3123e02d2894c83962ba402085b5e6422ebf8c73 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.77e-06 | 197 | 29 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.93e-06 | 198 | 29 | 4 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.09e-06 | 199 | 29 | 4 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.09e-06 | 199 | 29 | 4 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 8.25e-06 | 200 | 29 | 4 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.25e-06 | 200 | 29 | 4 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 85 | 29 | 3 | 5a2c02aeceeabd44a417b09ac8b2e2f185070b15 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 85 | 29 | 3 | 7c5ea38893372fdecf7cc3ccf46a37b4ec45f0b1 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 85 | 29 | 3 | 0bfabb6761a84d6a04f9fa415106a33059d78099 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.96e-05 | 102 | 29 | 3 | 72ce247dad7404e6b9c971b5c29d3c6846da5efc | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Abcc9_(Mural.Rgs5Acta2.Abcc9)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.96e-05 | 102 | 29 | 3 | 8c4d9483ff983538593f4e17f4a74a93cdda59c4 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.96e-05 | 102 | 29 | 3 | 5feedce6d26a578c4aaba4e4824b3d0c3f3806bc | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-05 | 113 | 29 | 3 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-05 | 113 | 29 | 3 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.06e-04 | 142 | 29 | 3 | 77fd145c1c500d580f70ac4e54c3fd879ecf0ab3 | |
| ToppCell | Epithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4) | 1.15e-04 | 146 | 29 | 3 | 4511916904c1fac252cb68e871b782207f8137b3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.30e-04 | 152 | 29 | 3 | 4f690aed23338687bdefc47e8a2f3d1fdb2b6447 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 153 | 29 | 3 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.37e-04 | 155 | 29 | 3 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 160 | 29 | 3 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.51e-04 | 160 | 29 | 3 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 160 | 29 | 3 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 1.51e-04 | 160 | 29 | 3 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 160 | 29 | 3 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.53e-04 | 161 | 29 | 3 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.53e-04 | 161 | 29 | 3 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 162 | 29 | 3 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 162 | 29 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 162 | 29 | 3 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 162 | 29 | 3 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 1.56e-04 | 162 | 29 | 3 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 162 | 29 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 1.59e-04 | 163 | 29 | 3 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 164 | 29 | 3 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 1.65e-04 | 165 | 29 | 3 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 167 | 29 | 3 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 167 | 29 | 3 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 167 | 29 | 3 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 167 | 29 | 3 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 168 | 29 | 3 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 169 | 29 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.80e-04 | 170 | 29 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 172 | 29 | 3 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | severe_influenza-B_memory|World / disease group, cell group and cell class (v2) | 1.86e-04 | 172 | 29 | 3 | 0ff38f9431cec73250c580a6010cb7891a3fe3f1 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-04 | 173 | 29 | 3 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-04 | 173 | 29 | 3 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | P07-Epithelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.90e-04 | 173 | 29 | 3 | 8b10087a917b825809d35a2b2b349c73a2782472 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-04 | 173 | 29 | 3 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.93e-04 | 174 | 29 | 3 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 174 | 29 | 3 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-04 | 174 | 29 | 3 | 62f5dc7086e1491fc90f005ccadfa1b772b52fad | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.93e-04 | 174 | 29 | 3 | 2739de68e0266054694f99807cfb1f07b6bbb371 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.93e-04 | 174 | 29 | 3 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| Drug | GK-101 | 1.22e-07 | 36 | 29 | 4 | CID000161853 | |
| Drug | hydroxylysine | 2.48e-07 | 109 | 29 | 5 | CID000001029 | |
| Drug | Madecassol | 3.34e-07 | 46 | 29 | 4 | CID000108062 | |
| Drug | d-indobufen | 4.69e-07 | 50 | 29 | 4 | CID000044562 | |
| Drug | ridogrel | 5.51e-07 | 52 | 29 | 4 | CID005362391 | |
| Drug | NSC49633 | 5.95e-07 | 53 | 29 | 4 | CID000023340 | |
| Drug | AC1LAKND | 1.12e-06 | 62 | 29 | 4 | CID000470146 | |
| Drug | BAPN | 1.94e-06 | 71 | 29 | 4 | CID000001647 | |
| Drug | malotilate | 1.94e-06 | 71 | 29 | 4 | CID000004006 | |
| Drug | AC1NMZ1B | 2.42e-06 | 75 | 29 | 4 | CID005034185 | |
| Drug | strontium ranelate | 2.69e-06 | 77 | 29 | 4 | CID006918182 | |
| Drug | halofuginone lactate | 4.00e-06 | 85 | 29 | 4 | CID000062891 | |
| Drug | 4-hydroxyproline | 5.25e-06 | 91 | 29 | 4 | CID000000825 | |
| Drug | ticlopidine | 8.60e-06 | 103 | 29 | 4 | CID000005472 | |
| Drug | AC1L1C2F | 1.12e-05 | 110 | 29 | 4 | CID000001711 | |
| Drug | PPACK | 1.24e-05 | 113 | 29 | 4 | CID003036757 | |
| Drug | AC1L9732 | 1.29e-05 | 114 | 29 | 4 | CID000439300 | |
| Drug | Tranilast sodium | 1.33e-05 | 115 | 29 | 4 | CID000005527 | |
| Drug | 2-Methyl-4-chlorophenoxyacetic Acid | 1.56e-05 | 5 | 29 | 2 | ctd:D008456 | |
| Drug | Selara | 1.85e-05 | 125 | 29 | 4 | CID000150310 | |
| Drug | DMSe | 2.29e-05 | 132 | 29 | 4 | CID000020796 | |
| Drug | pirfenidone | 2.73e-05 | 138 | 29 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 2.81e-05 | 139 | 29 | 4 | CID000004727 | |
| Drug | PCR 4099 | 2.81e-05 | 139 | 29 | 4 | CID000002806 | |
| Drug | candesartan cilexetil | 3.31e-05 | 145 | 29 | 4 | CID000002540 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 4.37e-05 | 314 | 29 | 5 | CID000447989 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 5.11e-05 | 162 | 29 | 4 | CID000072363 | |
| Drug | khellin | 6.30e-05 | 171 | 29 | 4 | CID000003828 | |
| Drug | AC1L1DD6 | 7.52e-05 | 179 | 29 | 4 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 9.29e-05 | 189 | 29 | 4 | CID000001413 | |
| Drug | foscarnet | 9.48e-05 | 190 | 29 | 4 | CID000003414 | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 3881_DN | |
| Drug | STOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 6561_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 1640_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 6069_UP | |
| Drug | calcium pyrophosphate | 1.13e-04 | 74 | 29 | 3 | CID000024632 | |
| Drug | AC1L8Y60 | 1.96e-04 | 89 | 29 | 3 | CID000410009 | |
| Drug | AC1Q6PCP | 1.98e-04 | 230 | 29 | 4 | CID000005267 | |
| Drug | prostacyclin sodium salt | 2.72e-04 | 250 | 29 | 4 | CID000000159 | |
| Drug | PtdIns(4)P | 3.10e-04 | 104 | 29 | 3 | CID000643965 | |
| Drug | hyaluronan | 3.29e-04 | 263 | 29 | 4 | CID000024759 | |
| Drug | silibinin | 4.46e-04 | 285 | 29 | 4 | CID000005213 | |
| Drug | LS-63783 | 4.51e-04 | 804 | 29 | 6 | CID000000231 | |
| Disease | myopathy (implicated_via_orthology) | 7.22e-10 | 48 | 27 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 1.49e-07 | 12 | 27 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 8.06e-07 | 2 | 27 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | Bartter disease type 4b (is_implicated_in) | 8.06e-07 | 2 | 27 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease type 4B | 8.06e-07 | 2 | 27 | 2 | cv:C4310805 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 8.06e-07 | 2 | 27 | 2 | C4746745 | |
| Disease | benign familial hematuria (is_implicated_in) | 8.06e-07 | 2 | 27 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 8.06e-07 | 2 | 27 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 8.06e-07 | 2 | 27 | 2 | 613090 | |
| Disease | Alport syndrome, recessive type | 8.06e-07 | 2 | 27 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 8.06e-07 | 2 | 27 | 2 | C2931253 | |
| Disease | Thin basement membrane disease | 8.06e-07 | 2 | 27 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 8.06e-07 | 2 | 27 | 2 | cv:C0241908 | |
| Disease | Bartter disease (implicated_via_orthology) | 8.06e-07 | 2 | 27 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B | 8.06e-07 | 2 | 27 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 8.06e-07 | 2 | 27 | 2 | C4310805 | |
| Disease | Alport syndrome | 2.42e-06 | 3 | 27 | 2 | cv:C1567741 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 2.42e-06 | 3 | 27 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Collagen IV-related nephropathies | 2.42e-06 | 3 | 27 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 4.83e-06 | 4 | 27 | 2 | C0241908 | |
| Disease | Alport Syndrome | 4.83e-06 | 4 | 27 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 8.05e-06 | 5 | 27 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 8.05e-06 | 5 | 27 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 8.05e-06 | 5 | 27 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 1.21e-05 | 6 | 27 | 2 | C0848548 | |
| Disease | Bartter syndrome | 1.21e-05 | 6 | 27 | 2 | cv:C0004775 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 3.61e-05 | 10 | 27 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | albuminuria | 8.66e-05 | 94 | 27 | 3 | EFO_0004285 | |
| Disease | T-Cell Lymphoma | 9.60e-05 | 16 | 27 | 2 | C0079772 | |
| Disease | Renal glomerular disease | 2.02e-04 | 23 | 27 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.02e-04 | 23 | 27 | 2 | C4521256 | |
| Disease | Hereditary hearing loss and deafness | 3.18e-04 | 146 | 27 | 3 | cv:C0236038 | |
| Disease | Congenital small ears | 6.47e-04 | 41 | 27 | 2 | C0152423 | |
| Disease | end stage renal disease (is_implicated_in) | 6.47e-04 | 41 | 27 | 2 | DOID:783 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPLQQGSPQMGGQTG | 221 | Q09472 | |
| GSPQMGGQTGLRGPQ | 226 | Q09472 | |
| QQQQQGAGPGIGPGM | 2191 | Q09472 | |
| GAGPGIGPGMANHNQ | 2196 | Q09472 | |
| QGEPGLQGTQGVPGA | 621 | Q01955 | |
| QMGDPGEVGQQGSPG | 241 | P53420 | |
| PQVPHGGSGGGQMGV | 111 | Q9P2D1 | |
| LQGVIGFPGMQGPEG | 56 | P02462 | |
| VQPGAGQLGMVQPGI | 736 | Q9H0J4 | |
| VQGMGQGTEGPGAVS | 1081 | Q9H0B3 | |
| MGQNGQEPVKQPGVG | 4981 | Q9Y6V0 | |
| QGSPGIPGMDGEQGL | 466 | Q9BXS0 | |
| VMGVGLPGQAAPGEG | 431 | Q6ZNL6 | |
| VVGPQGAAGETGPMG | 926 | P13942 | |
| PFMGVPVQGGGDPIQ | 251 | O95800 | |
| LTLTMGQGEPGGPQG | 46 | Q6MZN7 | |
| QQGGGMRFEGPSVPG | 1001 | O94913 | |
| MGIPGIGSQGEQGIQ | 446 | Q2UY09 | |
| IGSQGEQGIQGPIGP | 451 | Q2UY09 | |
| GEPGAVGQMGSPGQQ | 1261 | Q9P218 | |
| SQGQKGPQGSPGLMG | 1601 | A8TX70 | |
| GRTGVPPQQGMVPHG | 1401 | Q86UU0 | |
| MTGGIQGPGPINIGA | 471 | Q9H0L4 | |
| PGISGVGNPGAGMQG | 496 | Q9H0L4 | |
| VGNPGAGMQGTGIQG | 501 | Q9H0L4 | |
| VNPQGGNTGMVGGSV | 126 | Q8N465 | |
| GGPATQGPGMVVGDE | 291 | Q15436 | |
| GIVTGGVTNPIMPGG | 451 | P51800 | |
| GIVAGGITNPIMPGG | 451 | P51801 | |
| GPASQGVPMQGQGTI | 156 | O75177 | |
| AAGQAGMPGQAGPVG | 71 | P35247 | |
| GMPVVRGGQTVPGQA | 41 | Q96KM6 | |
| PMGGVGGQVQVSQPG | 1006 | Q9H4A3 | |
| QGSSGPQGHMGPQGP | 696 | Q9C0J8 | |
| QGHLGPQGPPGTQGM | 726 | Q9C0J8 | |
| GTQGMQGPPGPRGMQ | 736 | Q9C0J8 | |
| SGQGLPGVGIMPTVG | 4181 | O14686 |